ArticleJournal of obesity2025
Association Between Metabolic Syndrome and Incident Cervical Cancer: A Retrospective Cohort Study.
Article in Journal of obesity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine whether metabolic syndrome is associated with an elevated risk of cervical cancer. Methods: We retrospectively analyzed data on 1,410,650 women without a history of cancer, using the JMDC Claims Database, a nationwide epidemiological database in Japan, between 2005 and 2022. The look-back period was set at 2 years. Cox regression analyses were conducted to assess cervical cancer risk associated with metabolic syndrome and its components (waist circumference, blood pressure, triglycerides, high-density lipoprotein cholesterol, and fasting plasma glucose). Further, we conducted age-stratified analyses. Results: Metabolic syndrome was diagnosed in 43,029 participants (median age: 53 years), and 1579 cervical cancer cases were recorded over a median follow-up of 942 days. Multivariable Cox regression analyses showed that metabolic syndrome was associated with a higher cervical cancer incidence (hazard ratio [HR], 1.38; 95% confidence interval [CI], 1.04-1.82). Among the metabolic factors, cancer risk was associated with higher plasma glucose (per 10 mg/dL increase) (HR, 1.04; 95% CI, 1.01-1.08) and lower high-density lipoprotein cholesterol levels (per 10 mg/dL decrease) (HR, 1.06; 95% CI, 1.02-1.10), whereas waist circumference, blood pressure, or triglyceride levels showed no significant relationship. Metabolic syndrome was associated with an increased risk of cervical cancer, with a stronger association observed in younger women in age-stratified analyses ( Conclusion: Metabolic syndrome was associated with an increased risk of cervical cancer, with a stronger association observed among younger women. Elevated plasma glucose and low high-density lipoprotein cholesterol levels were identified as significant contributing factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.